First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting

By sjmartinez • September 29, 2024

Nicholas SB, Correa-Rotter R, Desai NR, Guo L, Navaneethan SD, Pantalone KM, Wanner C, Hamacher S, Fatoba ST, Horvat-Broecker A, Garreta-Rufas A, Gay A, Merz M, Wheeler DC. First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting. J Nephrol. 2024 Sep 28. doi: 10.1007/s40620-024-02070-y. Epub ahead of print. PMID: 39340711.

Tags: Chronic kidney disease, Finerenone, Nephrology, Non-interventional study, Publications, Type 2 diabetes

Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells

Stappenbeck F, Wang F, Sinha SK, Hui ST, Farahi L, Mukhamedova N, Fleetwood A, Murphy AJ, Sviridov D, Lusis AJ, Parhami F. Anti-Inflammatory Oxysterol, Oxy210,[...]

Prevalence and Outcomes of Chronic Kidney Disease Associated Pruritus: International Results from PDOPPS

Tennankore KK, McCullough KP, Bieber B, Cho Y, Johnson DW, Kanjanabuch T, Kawanishi H, Kim YL, Lambie M, Rigatto C, Shen J, Schreiber M, Perl[...]

Dianne Cheung, MD, MPH and Ramya Malchira, MD Appointed Associate Editors of Proceedings of the UCLA Department of Medicine

The UCLA Department of Medicine is pleased to announce that Dianne S. Cheung, MD, MPH and Ramya R. Malchira, MD have been appointed associate editors of Proceedings of the UCLA[...]